Loading people...
Harris Weber is a Principal at Bain Capital Life Sciences in Boston, Massachusetts, where he focuses on venture capital investments across the healthcare sector. Since joining the firm in 2017, he has specialized in sourcing, evaluating, and managing investments in clinical-stage medical technology and biotechnology companies. Previously, he worked in healthcare investment banking at JP Morgan, assisting pharmaceutical and biotech clients with mergers, acquisitions, equity offerings, and debt financings. Before his tenure in investment banking, he held a business development role at Vaccinex, a clinical-stage biotechnology enterprise focused on immuno-oncology and neurodegeneration. He graduated summa cum laude from the University of Rochester with a Bachelor of Science in cell and developmental biology and a Bachelor of Arts in business. Weber leverages his background in investment banking and biotechnology business development to evaluate emerging life sciences enterprises.
Harris Weber is a key member of the investment team at Bain Capital Life Sciences, where he holds the position of Vice President. Bain Capital Life Sciences is renowned for its deep expertise and strategic investments across the healthcare ecosystem, and Mr. Weber plays a crucial role in advancing the firm's mission to partner with innovative companies that are transforming patient outcomes.
As a Vice President, Harris Weber is actively involved in all stages of the investment process. His responsibilities include rigorous market research, identifying promising investment opportunities, conducting comprehensive due diligence, and structuring complex transactions. He works closely with portfolio companies post-investment, providing strategic guidance and operational support to help them achieve their growth objectives and maximize their impact within the life sciences sector.
Mr. Weber's investment focus areas align with the broad and dynamic landscape of life sciences. He targets companies operating in biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health. This encompasses a wide range of innovations, from novel drug discovery and development to advanced medical technologies and data-driven healthcare solutions. His expertise lies in evaluating companies with strong scientific foundations, compelling clinical data, and significant market potential, particularly those poised to address unmet medical needs or improve healthcare delivery.
Prior to his role at Bain Capital Life Sciences, Harris Weber developed a robust background in the financial and healthcare industries. His career trajectory typically involves experience in investment banking, management consulting, or other investment roles, where he honed his analytical skills, industry knowledge, and strategic acumen. This diverse experience provides him with a comprehensive understanding of the operational, financial, and regulatory complexities inherent in the life sciences sector, enabling him to identify and nurture high-potential ventures.
While specific individual investments by Vice Presidents are often part of broader firm-wide initiatives, Harris Weber contributes significantly to Bain Capital Life Sciences' impressive portfolio. The firm has a track record of backing groundbreaking companies that bring life-saving therapies and innovative technologies to market. Mr. Weber's work directly supports the firm's strategy of investing in both private and public companies across various stages of development, from early-stage growth equity to late-stage buyouts, all with the goal of fostering innovation and delivering strong returns.
Through his dedication and expertise, Harris Weber continues to be an integral part of Bain Capital Life Sciences' success in navigating the complex and rapidly evolving world of healthcare investment, ultimately contributing to advancements that benefit patients globally.
Harris Weber is a Vice President at Bain Capital Life Sciences, a prominent global investment firm focused on the healthcare sector. He plays a key role in identifying, evaluating, and executing strategic investments within the life sciences industry.
Harris Weber focuses on investments across various segments of the life sciences industry. This includes biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health solutions, targeting companies poised for significant growth and innovation.
Harris Weber works at Bain Capital Life Sciences, a leading global private equity firm with a dedicated focus on the healthcare and life sciences sectors. The firm has offices in Boston and New York.
